Home

Aspira Pathlab & Diagnostics Ltd PE Ratio

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

PE

98.7

Last updated on: Apr 02, 2025

Key Highlights

  • The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 98.7 as of 02 Apr 9.00 AM .
  • The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 21.3 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 80.97 as of 01 Apr 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 35.5 to 62.3 in 5 years. This represents a CAGR of 11.91%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.3. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd

No data available

Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

Share Price

₹ 80.97

-4.26 (-5.00%)

stock direction

Last updated on: Apr 01, 2025

Market Price of Aspira Pathlab & Diagnostics Ltd

1M

1Y

3Y

5Y

Monitoring Aspira Pathlab & Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
01 Apr 202580.97
28 Mar 202585.23
27 Mar 202589.71
26 Mar 202594.43
25 Mar 202599.39
24 Mar 2025101.7
21 Mar 202596.86
20 Mar 202592.25
19 Mar 202588
18 Mar 202588

SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Aspira Pathlab & Diagnostics Ltd

Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Aspira Pathlab & Diagnostics Ltd83.34
Max Healthcare Institute Ltd105332
Apollo Hospitals Enterprise Ltd95328
Fortis Healthcare Ltd51971
Narayana Hrudayalaya Ltd34261
Global Health Ltd33068

PE Ratio of Aspira Pathlab & Diagnostics Ltd Explained

83.34

Market cap

0

Earnings

98.7X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aspira Pathlab & Diagnostics Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in %

About Aspira Pathlab & Diagnostics Ltd

  • Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
  • ASDL is a leading pathology specialist, with Pan-India presence.
  • It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
  • The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
  • Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'.

Aspira Pathlab & Diagnostics Ltd News Hub

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as

Read more

14 Aug 24

Aspira Pathlab & Diagnostics to announce Quarterly Result

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 13 Augu

Read more

05 Aug 24

Aspira Pathlab & Diagnostics AGM scheduled

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be

Read more

28 Aug 24

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 Nove

Read more

30 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aspira Pathlab & Diagnostics Ltd

What is the current PE Ratio of Aspira Pathlab & Diagnostics Ltd?

The Current PE Ratio of Aspira Pathlab & Diagnostics Ltd is 98.74 as on 2 Apr 2025.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 62.3 as on 2 Apr 2025.

What was the PE Ratio of Aspira Pathlab & Diagnostics Ltd last year?

The PE Ratio of Aspira Pathlab & Diagnostics Ltd was 0.0 last year, now the PE ratio is 98.74, showing a year-on-year growth of -%.

What does the PE Ratio of Aspira Pathlab & Diagnostics Ltd indicate about its stock?

The PE Ratio of Aspira Pathlab & Diagnostics Ltd is 98.74. This ratio indicates that investors are willing to pay 98.74 times the earnings per share for each share of Aspira Pathlab & Diagnostics Ltd.

What is the PE Ratio Growth of Aspira Pathlab & Diagnostics Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aspira Pathlab & Diagnostics Ltd grew by -% whereas, the EPS ratio grew by -68.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions